Publications:

Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma.

Oncotarget

Takashima, Yasuo Y; Sasaki, Yasushi Y; Hayano, Azusa A; Homma, Jumpei J; Fukai, Junya J; Iwadate, Yasuo Y; Kajiwara, Koji K; Ishizawa, Shin S; Hondoh, Hiroaki H; Tokino, Takashi T; Yamanaka, Ryuya R

Publication Date: 2018-06-08

Variant appearance in text: HR: Arg775His

PubMed Link: 29937999

Variant Present in the following documents:

• Main text

View BVdb publication page